Plectin drives hepatocellular carcinoma progression and metastasis through cytoskeletal reorganization and oncogenic signaling, making it a promising therapeutic target for overcoming therapy ...

No conventional form of therapy is of practical value in the management of patients with diffuse primary or secondary liver tumors. This is also true in most cases of cancer of the gallbladder or ...

Liver cancer often remains undetected until advanced stages. Learn about the causes and how you can protect yourself with ...

Although histotripsy can successfully destroy tumors in the liver, longer-term data are still needed to see recurrence rates ...

Hepatocellular carcinoma (HCC) represents about 80 to 90% of cases of primary liver cancer. On a global level, 905,700 new ...

Pancreatic cancer remains one of the most challenging tumors to treat, partly because it is often discovered at advanced ...

Some patients are better candidates than others for histotripsy to treat liver tumors, but ultimately, this treatment still ...

If the hamartomas are fortuitously discovered by surgeons, then pathologists must distinguish these tumors from adenocarcinoma metastases. Male sex and benign liver tumor: an a priori suspicious ...

Transplantation combined with immunotherapy to cure liver cancer. Hepatocellular carcinoma (HCC) is the most common type of liver cancer in Switzerland and worldwide. Immunotherap ...

Researchers at Georgetown University have developed a new drug called CTPI-2, which targets a key gene known as Slc25a1. This ...

a targeted radiation therapy that reduces tumor size while sparing healthy liver tissue. Next, immunotherapy was used to boost the immune system's ability to fight the cancer. These combined ...